{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T01:10:04Z","timestamp":1734397804962,"version":"3.30.2"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijmmb.2024.100755","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T08:16:13Z","timestamp":1731831373000},"page":"100755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergistic approach of ertapenem and flucloxacillin or cefazolin for addressing persistent methicillin susceptible Staphylococcus aureus bacteremia"],"prefix":"10.1016","volume":"52","author":[{"given":"Yamuna Devi","family":"Bakthavatchalam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Karthik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamini","family":"Walia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harathi","family":"Ragothaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniya","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuvasri","family":"Manokaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijmmb.2024.100755_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100755_bib2","article-title":"Measuring beta-lactam minimum inhibitory concentrations in Staphylococcus aureus in the clinical microbiology laboratory: pinning the tail on the donkey","author":"Sakoulas","year":"2023","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ijmmb.2024.100755_bib3","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100755_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-018-3418-9","article-title":"Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis","volume":"18","author":"Shi","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ijmmb.2024.100755_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab148","article-title":"Oxacillin plus ertapenem combination therapy leads to rapid blood culture clearance and positive outcomes among patients with persistent MSSA bacteraemia: a case series","volume":"3","author":"El-Dalati","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"11","key":"10.1016\/j.ijmmb.2024.100755_bib6","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/AAC.01192-16","article-title":"Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia","volume":"60","author":"Sakoulas","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijmmb.2024.100755_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciz995","article-title":"Cefazolin and ertapenem salvage therapy rapidly clears persistent methicillin-susceptible Staphylococcus aureus bacteremia","volume":"71","author":"Ulloa","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijmmb.2024.100755_bib8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/jac\/dkae198","article-title":"Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia","volume":"79","author":"Shah","year":"2024","journal-title":"J Antimicrob Chemother"},{"year":"2018","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","key":"10.1016\/j.ijmmb.2024.100755_bib9"},{"year":"1999","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","key":"10.1016\/j.ijmmb.2024.100755_bib10"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100755_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmi.2017.07.003","article-title":"Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review","volume":"24","author":"Loubet","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ijmmb.2024.100755_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy123","article-title":"The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"5","author":"Miller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100755_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3181\/00379727-61-15222","article-title":"A test for penicillin sensitivity and resistance in Staphylococcus","volume":"61","author":"Luria","year":"1946","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.ijmmb.2024.100755_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/phar.2745","article-title":"Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate","volume":"43","author":"Hitchins","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ijmmb.2024.100755_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac159","article-title":"Potent activity of ertapenem plus cefazolin within staphylococcal biofilms: a contributing factor in the treatment of methicillin-susceptible Staphylococcus aureus endocarditis","volume":"9","author":"Gilbertie","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.ijmmb.2024.100755_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02166-21","article-title":"Is the success of cefazolin plus ertapenem in methicillin-susceptible Staphylococcus aureus bacteremia based on release of interleukin-1 beta?","volume":"66","author":"Smelter","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijmmb.2024.100755_bib17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/jocs.16491","article-title":"Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia","volume":"37","author":"Wilsey","year":"2022","journal-title":"J Card Surg"},{"key":"10.1016\/j.ijmmb.2024.100755_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/infdis\/jis552","article-title":"Elevated serum interleukin-10 (IL-10) at time of hospital admission is predictive of mortality in patients with Staphylococcu aureus bacteremia","volume":"206","author":"Rose","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijmmb.2024.100755_bib19","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.4049\/jimmunol.179.10.6933","article-title":"Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo","volume":"179","author":"Miller","year":"2007","journal-title":"J Immunol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085724002305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:29:00Z","timestamp":1734395340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085724002305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"alternative-id":["S0255085724002305"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100755","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic approach of ertapenem and flucloxacillin or cefazolin for addressing persistent methicillin susceptible Staphylococcus aureus bacteremia","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100755"}}